Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus
- 1 March 1992
- journal article
- Published by Springer Nature in Archiv für die gesamte Virusforschung
- Vol. 123 (1-2) , 135-143
- https://doi.org/10.1007/bf01317144
Abstract
Eleven groups of 8 pigs were vaccinated with different vaccinal strains of pseudorabies virus deleted or not for non-essential glycoproteins (gI, gX, gp 63), then were challenged 8–9 weeks later with a virulent strain. Antibodies against the major viral glycoproteins (gII, gIII, gp 50) were titrated at the day of challenge. Excretion of the challenge strain, growth performance of the pigs, and gI antibody responses from pigs vaccinated with a gI minus strain, were monitored after the challenge. The results demonstrated a strong association between gII and gIII antibody titres before the challenge, with the amount of the challenge strain excreted and clinical protection after the challenge. Furthermore, gI antibody titres after the challenge were negatively correlated with the level of gII and gIII antibodies at the day of challenge, the virus excretion and the clinical protection after the challenge. Implications of these results for vaccination of pigs and gI antibody screening for the infection are discussed.Keywords
This publication has 14 references indexed in Scilit:
- Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccinesVeterinary Microbiology, 1991
- Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccineJournal of General Virology, 1990
- Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-delecte Aujeszky's disease vaccinesVeterinary Microbiology, 1990
- Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virusVeterinary Record, 1989
- The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirementJournal of Biological Standardization, 1989
- Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodiesArchiv für die gesamte Virusforschung, 1988
- Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodiesVirology, 1986
- Differentiation of Serum Antibodies from Pigs Vaccinated or Infected with Aujeszky's Disease Virus by a Competitive Enzyme ImmunoassayJournal of General Virology, 1986
- Production and characterization of monoclonal antibodies directed against pseudorabies virusVirus Research, 1985
- Cell-mediated immunity in Aujeszky disease virus infected pigsArchiv für die gesamte Virusforschung, 1976